Your Location:
Home >
Browse articles >
Efficacy Mechanism of Xianlian Jiedu Prescription Against Colorectal Cancer Recurrence vias Regulating Angiogenesis
Updated:2025-03-04
    • Efficacy Mechanism of Xianlian Jiedu Prescription Against Colorectal Cancer Recurrence vias Regulating Angiogenesis

    • XU Yanru , TAO Lihuiping , QIAN Jingyang , SHEN Weixing , TAN Jiani , YU Chengtao , FAN Minmin , XU Changliang , LAI Yueyang , LI Liu , SUN Dongdong , CHENG Haibo
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 6, Pages: 79-87(2025)
    • DOI: 10.13422/j.cnki.syfjx.20241625     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 7 ) Tabs( 10 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

507

Views

606

Downloads

1

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Xianlian Jiedu Prescription Suppresses Colorectal Cancer EMT by Blocking Tumor-associated Macrophage-derived CCL5 Secretion and Inhibiting STAT3/β-catenin Signaling Pathway
Effect of Xianlian Jiedu Prescription Regulating Intestinal Flora and CD8+ T Cell Immune Response on Colorectal Cancer
Effect and Mechanism of Xianlian Jiedu Prescription Against Proliferation of Colorectal Cancer Cells in Hypoxic Microenvironment
Clinical Efficacy of Modified Linggui Zhugan Tang in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome of Spleen Deficiency and Dampness Obstruction with Blood Stasis Type and Its Effect on MIF, miR-223, and IL-18
Differential Analysis of Clinical Features and Outcomes Between Syndrome of Combined Phlegm and Stasis and Syndrome of Dampness-heat Internal Accumulation in Hepatic Wilson's Disease

Related Author

QIAN Jingyang
TAO Lihuiping
ZHANG Qinchang
SHEN Weixing
LI Liu
SUN Dongdong
CHENG Haibo
ZHUANG Yupei

Related Institution

Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, The First Clinical College, Nanjing University of Chinese Medicine
College of Pharmacy, Nanjing University of Chinese Medicine
The First Clinical College of Nanjing University of Chinese Medicine
School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine
The First Affiliated Hospital of Chongqing University of Chinese Medicine, Chongqing Traditional Chinese Medicine Hospital